<DOC>
	<DOC>NCT02100683</DOC>
	<brief_summary>The Nit-Occlud PDA Post-Approval Study is designed to continue to evaluate the safety and effectiveness of the device in the post-approval phase.</brief_summary>
	<brief_title>Nit-Occlud PDA Post-Approval Study</brief_title>
	<detailed_description />
	<mesh_term>Ductus Arteriosus, Patent</mesh_term>
	<criteria>Angiographically confirmed PDA with minimum diameter &lt; 4 mm. Weight is ≥ 5 kg. Age 6 months to 21 years. Cardiac anomalies requiring surgery. Known bleeding or coagulation disorder. Febrile illness within 7 days of planned procedure. Pregnancy. Pulmonary hypertension with increased pulmonary vascular resistance (≥ 5 Wood Units). Hypersensitivity to contrast medium. Known nickel allergy.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Occluder</keyword>
</DOC>